会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • WATER DISPERSIBLE FILM
    • 水分散膜
    • WO2005034854A3
    • 2005-06-09
    • PCT/US2004028178
    • 2004-08-30
    • NEW YORK BLOOD CT INCNEURATH ALEXANDER ROBERTSTRICK NATHANLI YUN-YAO
    • NEURATH ALEXANDER ROBERTSTRICK NATHANLI YUN-YAO
    • A61K9/00A61K9/70A61K31/716A61F13/00
    • A61K31/716A61K9/0034A61K9/7007
    • A soft, pliable cellulose acetate phthalate (CAP) - hydroxypropyl cellulose (HPC) composite film is provided which is generated by casting from organic solvent mixtures containing ethanol. The film rapidly reduces the infectivity of several sexually transmitted disease pathogens, including the human immunodeficiency virus (HIV-1), herpesvirus (HSV), non-viral sexually transmitted disease pathogens (such as Neisseria gonorrhoeae, Haemophilus ducreyi, Chlamydia trachomatis and Treponema pallidum) and bacteria associated with bacterial vaginosis (BV). The film is converted into a gel/cream and thus does not have to be removed following application and use. In addition to being a topical microbicide, the film can be employed for the mucosal delivery of pharmaceuticals other than cellulose acetate phthalate.
    • 提供柔软的,柔韧的乙酸邻苯二甲酸纤维素(CAP) - 羟丙基纤维素(HPC)复合膜,其通过从含有乙醇的有机溶剂混合物中浇铸而产生。 该片迅速降低了几种性传播疾病病原体的感染性,包括人类免疫缺陷病毒(HIV-1),疱疹病毒(HSV),非病毒性传播疾病病原体(如淋病奈瑟氏球菌,杜氏血吸虫,沙眼衣原体和苍白密螺旋体 )和细菌性阴道炎相关的细菌(BV)。 该胶片被转化为凝胶/霜剂,因此在使用和使用后不需要除去。 除了是局部杀微生物剂之外,该膜还可用于除了邻苯二甲酸乙酸纤维素之外的药物的粘膜递送。
    • 6. 发明申请
    • RAPIDLY DISPERSIBLE VAGINAL TABLET THAT PROVIDES A BIOADHESIVE GEL
    • 提供生物凝胶的快速不平的血管片
    • WO2008148018A2
    • 2008-12-04
    • PCT/US2008064737
    • 2008-05-23
    • NEW YORK BLOOD CT INCSTONE ALANNEURATH ALEXANDER ROBERTSTRICK NATHANJIANG SHIBO
    • STONE ALANNEURATH ALEXANDER ROBERTSTRICK NATHANJIANG SHIBO
    • A61K9/20
    • A61K9/0034A61K9/2018A61K31/00
    • A tablet for insertion into a vagina including 0.01 to 500 mg of a vaginal medication, such as a microbicide, such as cellulose acetate 1,2- benzenedicarboxylate (CAP); 100 to 500 mg of mannitol powder; 50 to 300 mg of inert microcrystalline cellulose; 10 to 80 mg of hydroxypropyl methylcellulose; 50 to 250 mg of glycerol and optionally 2 to 4 mg of at least one preservative which protects against microbicidal contamination and discourages the growth of yeast in the vagina. The tablet which includes CAP as the vaginal medication is vaginally administered before coitus in methods for preventing the sexual transmission of HIV- 1, HIV-2, herpesvirus, or an infection caused by Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Haemophilus ducreyi or Treponema pallidum. The tablet which includes CAP as the vaginal medication is vaginally administered to prevent or treat bacterial vaginosis.
    • 用于插入阴道的片剂,其包含0.01至500mg的阴道药物,例如杀微生物剂,例如1,2-乙二羧酸纤维素酯(CAP); 100〜500mg甘露糖醇粉末; 50〜300mg惰性微晶纤维素; 10至80mg羟丙基甲基纤维素; 50至250mg的甘油和任选的2至4mg的至少一种防腐剂,其防止杀微生物污染并阻止酵母在阴道中的生长。 包括CAP作为阴道药物的片剂在防止HIV-1,HIV-2,疱疹病毒的性传播或由淋病奈瑟氏球菌,沙眼衣原体,阴道毛滴虫,杜氏乳杆菌或密螺旋体感染引起的感染的方法之前阴道给药 梅毒螺旋体。 包括CAP作为阴道药物的片剂被阴道施用以预防或治疗细菌性阴道病。